首页> 外文期刊>Emergency medicine journal: EMJ >Best evidence topic reports. Is intravenous aminophylline better than intravenous salbutamol in the treatment of moderate to severe asthma?
【24h】

Best evidence topic reports. Is intravenous aminophylline better than intravenous salbutamol in the treatment of moderate to severe asthma?

机译:最佳证据主题报告。在中度至重度哮喘的治疗中,静脉给予氨茶碱是否比静脉给予沙丁胺醇更好?

获取原文
获取原文并翻译 | 示例
           

摘要

A short cut review was carried out to establish whether intravenous salbutamol or intravenous aminophylline offers the quickest and least complicated treatment for patients with moderate to severe asthma not responding to inhaled therapy. Altogether 71 papers were found using the reported search, of which nine presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. A clinical bottom line is stated.
机译:进行了简短的回顾,以确定对于中度至重度哮喘对吸入疗法无反应的患者,静脉注射沙丁胺醇或氨茶碱是否能提供最快,最简单的治疗。报告检索共发现71篇论文,其中9篇是回答临床问题的最佳证据。这些最佳论文的作者,出版日期和国家,研究的患者组,研究类型,相关结果,结果和研究缺点都列在表格中。说明了临床底线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号